Compare HRTX & SOCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HRTX | SOCA |
|---|---|---|
| Founded | 1983 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 203.5M | 235.0M |
| IPO Year | 1987 | 2025 |
| Metric | HRTX | SOCA |
|---|---|---|
| Price | $1.33 | $10.08 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $4.50 | N/A |
| AVG Volume (30 Days) | ★ 2.0M | 28.5K |
| Earning Date | 11-04-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $155,097,000.00 | N/A |
| Revenue This Year | $8.98 | N/A |
| Revenue Next Year | $11.57 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 12.60 | N/A |
| 52 Week Low | $1.00 | $9.94 |
| 52 Week High | $2.68 | $10.15 |
| Indicator | HRTX | SOCA |
|---|---|---|
| Relative Strength Index (RSI) | 66.48 | N/A |
| Support Level | $1.10 | N/A |
| Resistance Level | $1.37 | N/A |
| Average True Range (ATR) | 0.08 | 0.00 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 90.41 | 0.00 |
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
Solarius Capital Acquisition Corp is a blank check company.